← Back to all trials
Recruiting
NCT06059638
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Conditions: Hypertension, Hypertension, Systolic, Hypertension, Essential
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 316
Sponsor: Orchestra BioMed, Inc
Location: HonorHealth Scottsdale Arizona
Summary
A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.
Eligibility Criteria
Inclusion Criteria:
1. Patient has or is indicated for a dual-chamber pacemaker. Visit 1 can be performed within 30 days prior to a planned implant of a Medtronic Astra/Azure dual-chamber pacemaker system or at any time thereafter
2. On a stable antihypertension treatment regimen with at least 1 class of antihypertensive drug
3. Office SBP ≥135 mmHg and \
Source: ClinicalTrials.gov (NCT06059638). StuddyBuddy aggregates publicly available trial information.
